MetLife (NYSE:MET) Coverage Initiated at BMO Capital Markets

Equities researchers at BMO Capital Markets began coverage on shares of MetLife (NYSE:MET) in a note issued to investors on Thursday, Marketbeat.com reports. The firm set a “market perform” rating and a $97.00 price target on the financial services provider’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.84% from the company’s previous close.

MET has been the subject of several other research reports. Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Wells Fargo & Company dropped their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen upped their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Finally, Barclays raised their target price on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.46.

MetLife Stock Down 0.9 %

Shares of MET opened at $85.96 on Thursday. The business’s fifty day moving average price is $83.76 and its two-hundred day moving average price is $79.87. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $59.52 billion, a price-to-earnings ratio of 17.33, a PEG ratio of 0.65 and a beta of 1.07. MetLife has a 52 week low of $64.61 and a 52 week high of $89.05.

Institutional Investors Weigh In On MetLife

Several institutional investors have recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC raised its holdings in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its stake in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in MetLife during the 3rd quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC acquired a new position in shares of MetLife during the 4th quarter worth about $32,000. Institutional investors own 94.99% of the company’s stock.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.